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Abstract
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In the following respects, tooth enamel is a unique tissue in the mammalian body: (a) it is the most
mineralized and hardest tissue in it comprising up to 95 wt% of apatite; (b) its microstructure is
dominated by parallel rods composed of bundles of 40 – 60 nm wide apatite crystals with aspect
ratios reaching up to 1:10,000 and (c) not only does the protein matrix that gives rise to enamel
guides the crystal growth, but it also conducts its own degradation and removal in parallel. Hence,
when mimicking the process of amelogenesis in vitro, crystal growth has to be coupled to
proteolytic digestion of the amelogenin assemblies that are known to play a pivotal role in
conducting the proper crystal growth. Experimental settings based on controlled and
programmable titration of amelogenin sols digested by means of MMP-20 with buffered calcium
and phosphate solutions were employed to imitate the formation of elongated, plate-shaped
crystals. While amelogenin can act as a promoter of nucleation and crystal growth alone, in this
study we show that proteolysis exerts an additional nucleation- and growth-promoting effect.
Hydrolysis of full-length amelogenin by MMP-20 decreases the critical time needed for the
protein and peptides to adhere and to cover the substrate. The formation and immobilization of a
protein layer subsequently reduces the time for calcium phosphate crystallization. Coupling the
proteolytic reaction to titration in the presence of 0.4 mg/ml rH174 has been shown to have the
same effect on the crystal growth promotion as quadrupling the concentration of rH174 to 1.6 mg/
ml. Controlling the rate and the extent of the proteolytic cleavage can thus be used to control the
nucleation and growth rates in a protein-guided crystallization system.

Introduction
The biological formation of enamel tissue is known as amelogenesis and gives rise to the
hardest tissue in the vertebrate body. Besides specialized cells, the ameloblasts, it involves
macromolecular species that can be divided into families of proteins, proteases and protease
inhibitors. Ninety percent of proteins that make up the enamel matrix are derived from the
© 2011 Elsevier Ltd. All rights reserved.
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amelogenin gene, with the full-length protein being expressed predominantly (90%). The
remaining 10 % is comprised of other proteins: ameloblastin, enamelin, and proteolytic
enzymes. Together, they assemble into a scaffold that serves as a template for the nucleation
and uniaxial growth of apatite crystals in a highly organized structure (1). Recent findings
suggests that mineralization and assembly occurs simultaneously in developing enamel and,
hence, amelogenesis differs from bone formation in this respect (2, 3). The role of
amelogenin in guiding apatite formation has been ascribed to its ability to self-assemble into
nanospheres and nano-chains (4-6).
One of the most intriguing features of amelogenesis derives from the fact that its high
mineral content coupled with an ultrafine architecture implies the extracellular matrix in this
process directs not only the crystal growth, but its own constructive degradation too. This
makes amelogenesis a significantly more intricate mineralization process compared to
dentinogenesis during which the collagenous protein matrix remains in place (7). Studies of
proteolysis of the enamel matrix are thus of particular importance in attempts to understand
amelogenesis (8-10).
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The action of proteases, such as matrix metalloproteinase-20 (MMP-20, also known as
enamelysin) and kallikrein 4 (KLK-4, also known as enamel matrix serine protease 1) in
hydrolysis of amelogenins and other proteins thus presents a crucial aspect of amelogenesis
(11). The initially secreted nascent proteins are present in the enamel matrix in transient
form, and are relatively quickly processed to generate a wide spectrum of smaller peptides.
Due to its high selectivity for specific peptide bonds, MMP-20 is usually considered a
regulator that controls the functionality of amelogenins (12). The latter proteins ought to be
removed once the structure of enamel is sufficiently formed, so that the freed space would
be filled with additionally crystallized apatite. Thin fibrous crystals form during secretory
stage while MMP-20 hydrolyses matrix proteins producing specific cleavage products. Only
at maturation stage crystals will grow in width and thickness, into areas where protein is
being removed by activity of KLK-4 (13). Most of the mineral deposition is therefore known
to occur during maturation stage of amelogenesis when the degradation and removal of the
enamel matrix take place. Crystals extend and come in close contact with each other and a
tissue with 95 wt% mineral forms (14)(15).
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An increasing amount of evidence suggests that the cleavage products carry out different
secondary self-assembly-related functions in the developing enamel matrix (16). Hence, it
was shown that mixtures of the full-length human amelogenin (rH174) and the first
proteolytic cleavage product formed in the reaction with MMP-20, rH163, possess a
markedly higher propensity for the formation of more complex, fibrous protein assemblies
from the initial nanospheres compared to the pure rH174 (17). The structure of amelogenin
is thus thought to be modular, in a sense that it may contain several functional domains that
become activated for different purposes and at different stages of amelogenesis (18). This
idea is supported by the findings that the metallo-matrix protease is expressed early during
development (16). Mutations not only in amelogenin genes, but in those that encode
MMP-20 cause amelogenesis imperfecta, i.e., a pathological state typified by abnormal and
significantly weakened enamel (16, 19). Knockout of MMP-20 in mice resulted in the
formation of hypoplastic enamel composed of thin, shorter crystallites with undefined
prisms, indicating that MMP-20 hydrolysis is required for proper lateral extension of
crystals (20, 21). Another study shows that impaired enzymatic interaction between
MMP-20 and amelogenin may be the prime cause of amelogenesis imperfect (22). Inhibition
of the activity of MMP-2, MMP-9 and MMP-20 by marimastat similarly led to impaired
mineralization of dental tissues in mice (23). MMP-20 by itself was not able to remove the
matrix to a degree that allowed formation of functional enamel as shown by the KLK-4 KO
mouse (24).
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Our approach to gaining insight into the mechanism of amelogenesis at the molecular scale
involved the design of a biomimetic programmable titration system (25). Slow and
controlled titration of amelogenin sols with buffered calcium and phosphate solutions at low
degrees of saturation is thus employed to imitate the formation of elongated enamel-like
crystals. In our previous report, we claim that despite its predominantly hydrophobic nature,
amelogenin acts as a promoter of nucleation and crystal growth under the biomimetic
conditions of growth applied in our study (26). In this paper, we report on our results on
calcium phosphate formation in the given system in the presence of the proteolytic
degradation of full-length amelogenin by means of MMP-20.

Experimental

NIH-PA Author Manuscript
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Recombinant full-length human amelogenin (rH174) and MMP-20 were previously
synthesized via their expression in BL21(DE3) plysS Escherichia Coli (27, 28). The
experimental setting applied in this study was modified from a previous study (25).
Titrations were performed with 1 ml burettes, using a Titrino 751 GDP titration device in
combination with a Dosimat 755 (Brinkmann-Metrohm) controlled by computer software
(Tiamo 1.2, Brinkmann-Methrohm). The basic procedure was as follows. If not denoted
otherwise, the starting reaction mixture comprised 5 ml of 0.4 mg/ml rH174, 20 mM Tris/
HCl buffer, 2.5 mM KH2PO4, and 0.02 % NaN3 (introduced to the system in the given
sequence) at pH 7.40 +- 0.01. The reaction mixture was prepared and kept in a jacketed
glass vessel during titration, which was maintained at 37°C via a circulating water bath. The
two buffered titrant solutions (20 mM Tris/HCl, pH 7.40 +- 0.02) comprising the separate
precursor ions (8.2 mM CaCl2 and 5 mM KH2PO4) and the electrolyte (142 mmoll-1 KCl)
up to the level of the physiological ionic strength were introduced into the reaction vessel at
a controlled rate of 840 nl/min, i.e., 1.2 ml/day, cumulatively, throughout a 7-day period of
time. In order to ensure substrate-specific crystal growth, it was essential to start the titration
at undersaturated conditions. This was achieved by preparing the reaction mixture without
calcium ions initially. Calcium content increased gradually during titration whereas
phosphate was added at concentrations which would maintain its level around 2.5 mM.
MMP-20 was added at the start of the experiment in different weight ratios with respect to
rH174, ranging from 1:103 to 1:105. In order to ensure invariance in terms of ionic
concentrations, we compared all our reaction solution concentrations with controls, which
comprised either protease-free or protein-free systems. To deduce the effect of MMP-20
concentration on crystal growth, the concentration of ions before the onset of precipitation
was made identical for all the compared reaction systems (MMP-20/rH174 = 0; 1:105;
1:103). The crystal growth was initiated on polished glass ceramic substrates comprising
embedded fluoroapatite (FAP) crystals with surface-exposed (001) faces (29). A single
substrate was sampled out at different time points and evaluated for the crystal growth
properties using Atomic Force Microscopy (AFM, Nanoscope III, Digital Instruments, USA)
and Scanning Electron Microscopy (SEM, DS130C, Topcon, USA). Tapping-mode AFM
was applied using Si-tips with a radius of about 10 nm (Tap300, Budgetsensors, USA). The
crystal heights were measured using the section analysis tool in NanoScope software.
Heights of twelve randomly chosen peaks in three different 10 × 10 μm2 AFM images were
measured and the average values were plotted as a function of the titration volume. As the
substrate surface was uniformly covered with the precipitate, it was assumed that 36
randomly chosen peaks would be sufficient to obtain a representative assessment of the
substrate topology. Aliquots of 200 μl of the supernatants were also sampled out daily. A
part of the aliquots was mixed with 2 M HCl at 1:1 weight ratio to stop the proteolytic
digestion, and another part was filtered and used for the elemental analysis using Inductively
Coupled Plasma Optical Emission Spectrometry (ICP-OES, Perkin Elmer, 5300 DV). The
concentration of Ca2+ and PO4 3- in the reaction solution was followed in parallel using a
calcium ion-selective electrode (pHoenix) and a UV/Vis/IR spectrophotometer (Milton Roy,
Arch Oral Biol. Author manuscript; available in PMC 2012 December 1.
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Genesys 5), respectively. The calcium concentrations reported correspond to free calcium
ions in the solution and do not account for those bound to the peptide species. The need to
derive the exact activity coefficients has been partly eliminated by using the difference
between the output calcium levels for various protease concentrations to draw conclusions
about the nucleation and crystal growth promoting effect that MMP-20 induced. The amount
of precipitated calcium ions was calculated by subtracting the amount of calcium present in
the reaction mixture at a given time (the sum of the initial amount and the amount added by
titration normalized for the evaporation effect) from the amount of calcium indicated by the
ion-selective electrode.
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Dynamic light scattering (DLS) analysis of colloidal suspensions of proteolytically cleaved
rH174 was carried out on Zetasizer Nano-ZS (Malvern, UK) device. SDS–PAGE of cleaved
amelogenin was carried out in 8% (w/v) polyacrylamide gel at pH 8.8 as described by
Laemmli (30). The gels were stained with Coomassie brilliant blue R-250. Samples used for
the SDS-PAGE analysis were previously subjected to a dialysis treatment using 20 mL
protein buffer exchange dialysis cups (Fisher Scientific) in 10 mM EDTA in order to
eliminate Ca2+ and HxPO4 x-3 ions and to raise the pH to neutral values. With the given gel
composition used, only cleavage products larger than 15 kDa could be discerned. To detect
smaller proteolytic digestion fragments, matrix-assisted laser desorption ionization mass
spectrometry and tandem mass spectrometry (MALDI MS and MS/MS) analysis was carried
out. For that purpose, the samples from MMP-20 digestion at different time points were
desalted by ZipTip pipette tips (Millipore, Billerica, MA) packed with C18 resin. The
eluates from ZipTip were mixed with MALDI matrix α-cyano-4-hydroxycinnamic acid (6
mg/ml in 80% ACN/0.1% TFA/10 mM dibasic ammonium phosphate) and manually spotted
onto a stainless steel MALDI plate (Applied Biosystems (AB), Foster City, CA). The
sample spots on the MALDI plate were analyzed with a 5800 MALDI TOF-TOF Protemoics
Analyzer (AB) in both linear and reflector positive modes in the mass range of
800-40,000Da and 800-6,000Da, respectively. About 30 peaks from the reflector MS spectra
of two samples obtained at 24 hour of MMP-20 digestion were manually selected for MS/
MS. Database search of these MS/MS spectra against Uniprot human database (with
common contaminants) using ProteinPilot software (Version 3.0, Revision 114732, AB)
resulted in confident identification of amelogenin in both samples. The experimental
molecular mass of rh174 was 19818 Da, i.e., it was measured within a 0.07% error that is
consistent with the expected accuracy of the AB Sciex 4800 TOF/TOF mass spectrometer
when analyzing protein species of ~20 kDa using linear mode. Table 1 lists samples
analyzed by means of SDS-PAGE and MALDI-TOF after being sampled out at various
titration time points.
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Results
Cleavage of rH174 by MMP-20
Fig.1 shows SDS-PAGE gel of the proteolytically digested full-length amelogenin (rH174)
samples in the continuous titration experiments sampled out at various time points, ranging
from 2 min to 24 h. The intensity of the rH174 band decreases over time, suggesting timedependent proteolytic cleavage, irrespective of the concentration of the protease (rH174/
MMP-20 103:1 or 104:1). For 103:1 rH174/MMP-20 weight ratio, the maximum cleavage of
rH174 takes place between 2.5 h and 24 h. Between 2 min and 2.5 h, the intensity of the fulllength band decreases for both rH174/MMP-20 weight ratios, suggesting gradual cleavage
of the protein. For 104:1 rH174/MMP-20 weight ratio, the full cleavage of rH174 takes place
between 4 h and 24 h. rH174 band for 104:1 rH174/MMP-20 weight ratio after 5 min is
more intensive than the one for 103:1 ratio after 2 min, suggesting quicker initial digestion at
higher concentrations of the protease. Whereas the full-length band is hardly visible after 4 h
for 103:1 concentration, the band after 4 h for 104:1 weight ratio is as intensive as that at
Arch Oral Biol. Author manuscript; available in PMC 2012 December 1.
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early time points for 103:1 ratio. rH163 is known to be the first proteolytic product of the
digestion of rH174 with MMP-20. The fact that it could not be discernable by means of
SDS-PAGE may be partly due to its closeness to the rH174 band, and partly due to the
earlier evidenced quick processing thereof to smaller peptide fragments (28).
Analysis of cleaved products
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Mass spectra (0.8 – 42 kDa) of samples acquired in the linear positive mode are shown in
Fig.2a,b. Three major peaks at 19.82, 9.91 and 6.0 kDa correspond to singly, doubly, and
triply charge states of rH174. From A1(2 min) to A3(30 min) and from B1(5 min) to B2(30
min), there is a minimum change in the spectral appearance, with slightly more abundant
rH174 peptides seen in the low-mass range of A3(30 min) and B2(30 min), respectively.
Compared to A3(30 min), significantly more abundant rH174 peptides can be seen in A6(5
h), while rH174 peaks remain to be abundant in A6(5 h). More abundant rH174 peptides
were seen in B4(4 h) as compared to B2(30 min). However, the difference between B2(30
min) and B4(4 h) is less significant than that found between A3(30 min) and A6(5 h), which
is the consequence of the 10 times higher rH174/MMP-20 ratio for the B series (rh174/
MMP-20 : 104) of samples compared to A (rh174/MMP-20 : 103). For both sample series,
the spectra of the last samples (A7, 24 h and B5, 24 h) lacked the presence of full-length
amelogenin rH174, indicating the hydrolysis of the protein by MMP-20. A few peaks were
observed in the medium mass range (8 – 20 kDa) at 24 h. Those peaks around 8.3, 9.2, 11.5,
12.3, 13.6, 15.1 and 16.7 are most likely hydrolysis products of rH174 which may not be
hydrolyzed by MMP-20 at all and require KLK-4 for processing (31).
Fig.2c,d shows mass spectra (0.8 – 6 kDa) of samples acquired in the reflector positive
mode. As indicated by the linear mass spectrograms, an increasing amount of rH174
peptides is seen with the increase in the titration time, that is, from sample A1 (2 min) to A7
(24 h) and from B1 (5 min) to B5 (24 h). Aside from singly, doubly and triply charged
rH174, the only rH174 fragment larger than 5 kDa observed in the first 4 h of digestion time
was 1-116 sequence at 13.2 kDa, corresponding to the cleavage loci PVQ/PQP. The MS/MS
spectra were manually acquired for most of the peaks observed in the reflector mass spectra
of samples A7 and B5 (Fig.3c,d). Database search of those MS/MS spectra using
ProteinPilot identified amelogenin as the only positive hit in both cases. Table 2 shows
selected MMP-20 cleavage sites on rH174 sequence after 5 min and 24 h of digestion time.
Effect of proteolysis on crystal growth and morphology
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The effect of proteolysis on the crystal growth promoting capacities of rH174 sols can be
also seen from AFM images and curves depicting apatite crystal height as a function of the
titration volume for different rH174/MMP-20 weight ratios, displayed in Fig.4a-c. The
earliest precipitation covering almost the entire surface of the substrates was noticed after 4
ml of titration without MMP-20, corresponding to 3.5 days of titration. The time for
precipitation was significantly reduced when MMP-20 was added to the system. At a ratio of
105:1 of rH174/MMP-20 precipitation was observed after 2.8 ml or about 2 days; and after
only 1.5 ml or about 30 hours of titration with rH174/MMP-20 103:1 ratio. In the latter case,
the level of growth was more significant after 24 h than after 7 days in the protease-lacking
experiment. Note that the z-scale limit for AFM imaging is around 3 μm with the standard Jtype piezo scanner, but the real thickness of the final precipitate was more in the order of 50
μm as shown in the SEM image of Fig.3d.
The effect of proteolysis on the rH174 particle size increase at pH 7.4, as indicated by
dynamic light scattering measurements, is shown in Fig.4. Namely, approximately 2 h after
mixing 0.4 mg/ml rH174 with MMP-20 in 100:1 weight ratio, amelogenin particle size
began to increase from ~ 40 nm, reaching 180 nm 3 h after the addition.

Arch Oral Biol. Author manuscript; available in PMC 2012 December 1.
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Despite the fact that all the experimental systems were buffered, in most cases a mild drop in
pH, most likely associated with the precipitation of apatite, was noticed. Fig.6a shows a
different extent of this drop depending on the protein content of the reaction system. When
proteolytic cleavage was coupled to the precipitation reaction, the system exhibits a more
intensive pH drop (down to pH 6.8) compared to the non-protease-containing reaction
(down to pH 7.2). Also, it was observed that whereas in the protease-free rH174 sol the
concentration of phosphates stabilizes at around 1.5 mM, it drops to below 0.5 mM in the
titrated protease-containing rH174 suspension after > 3 ml of titration volume.
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Gradual increase of the calcium levels in the solution typically results in a plateau in [Ca2+]
vs. titration time/volume curves, which is an indication of the onset of precipitation of
calcium phosphate. Fig.6a shows how the experimental runs performed in the presence of
the proteolytic cleavage of rH174 exhibit lower free Ca2+ levels compared to the runs
comprising full-length rH174 as well as the control runs without any peptide species
throughout the entire 7-day reaction time. As the quantity of Ca2+ ions obtained by
subtracting the measured free levels from the overall titrated amount can be accounted for
either the peptide-bound ionic species or the precipitated ones, this observation speaks in
favor of MMP-20 digestion promoting even more of the crystal growth and Ca2+-binding
compared to pure rH174-comprising suspensions. As shown in Fig.6b, the amount of Ca2+
ions that was bound to the protein or precipitated after 1 ml of the titration volume was
lower than 50 % with respect to the overall titrated amount of calcium ions, whereas at the
same reaction time this amount exceeded 80 % when rH174 in concentration of 1.6 mg/ml
was used or when MMP-20 at rH174:MMP-20 weight ratio of 103:1 was introduced to the
system. Interestingly, coupling the proteolytic reaction to crystallization in the presence of
0.4 mg/ml rH174 has the same effect on the crystal growth promotion as quadrupling the
concentration of full-length rH174 to 1.6 mg/ml.
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SEM micrographs (Fig.7) demonstrated that the proteolytic reaction affected the size of the
basal planes of calcium phosphate crystals, but it did not catalyze a morphological change.
In all cases, plate-shaped particles were observed. Higher contents of MMP-20 lead to a
decrease in the crystal width (Fig.7b, c) when compared to protease-free experiments (Fig.
7a). EDX analysis has indicated the presence of calcium and phosphorus, whereas Raman
analysis has confirmed the presence of apatite as the main calcium phase (ν1(PO4) = 956
cm-1). Fig.8 shows the different appearance of FAP substrates at early and late titration time
points. At earlier times (Fig.8a), the substrate surface is mostly covered with the protein
precipitate, which presents the first step in substrate-specific crystal growth. As can be seen
from the inset in Fig.8a, the initial protein precipitate shows only traces of calcium and
phosphorus ions. Morphologies reminiscent of the nucleating calcium phosphates appear as
visible under the initially deposited protein layers in the next steps, as shown on the left side
of the FAP substrate in Fig.8b. Eventually, most of the substrate surface becomes covered
with plate-shaped calcium phosphate particles, such as those on the right side of the SEM
image in Fig.8b.

Discussion
In our previous report, we have offered evidence in favor of the nucleation and growth
promoting role of rH174 under the experimental conditions applied in our biomimetic study
(26). Biomimetic conditions under which crystallization proceeded kinetically driven by the
ability of rH174 to concentrate and nucleate ionic growth units within its deposited layers,
rather than by the thermodynamic propensities of the solution, were established and a
mechanism for the amelogenin-guided crystal growth based on the observed nucleation of
calcium phosphate within amelogenin layers deposited on the FAP substrate surface was
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a.

The more MMP-20 is initially present in the system, the earlier in the course of the
titration time the precipitation of mineral begins and the more intensive the crystal
growth becomes (Fig.3);

b. The extent of the pH drop associated with the formation of apatite was higher for
the protease-containing system compared to its solely rH174-comprising
counterpart (Fig.5);
c.

When MMP-20-induced digestion of rH174 is coupled to precipitation of calcium
phosphate lower concentrations of calcium ions in the supernatants through the
entire course of the experiment (Fig.6a) and lower final concentrations of
phosphates indicate more extensive precipitation of ions in the protease-containing
systems compared to the protease-free ones;

d. Coupling the proteolytic reaction to titration in the presence of 0.4 mg/ml rH174
has the same effect on the crystal growth promotion as quadrupling the
concentration of rH174 to 1.6 mg/ml (Fig.6b).
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These observations strongly indicate that the proteolytic digestion plays an additional
nucleation promoting role when compared to the control, protein-free experiment and the
one containing rH174 as the only polypeptide compound. By lowering the energy of
activation required for heterogeneous nucleation, proteolysis influences the thermodynamics
of apatite growth. The first proteolytic product of the reaction between rH174 and MMP-20
is the 13-26 residues long C-terminal sequence of a pronounced hydrophilicity (Table 1).
Such a loss of the amphiphilic character of the cleaved rH174 results in increased propensity
to form larger nanospheres as well as to aggregate and precipitate (32) (Fig.6). Since
deposition of the aggregated protein assemblies on the FAP substrate surface presents the
first step prior to the crystal growth (Fig.8), the proteolytic cleavage thus leads to enhanced
nucleation and apatite formation.
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The rate of the proteolytic cleavage reaction has been shown to be directly proportional to
the concentration of MMP-20. In 24 h, a complete digestion of rH174 into smaller peptide
fragments takes place at both 103:1 and 104:1 rH174/MMP-20 weight ratios (Figs. 2, 3). The
number of peptides smaller than 5 kDa increased from ~ 30 to ~ 140 as the digestion time
increased from 5 min to 24 h (Table 2). Also, all 12 most intense rH174 peptides generated
after 5 min of digestion time come from N- or C- termini compared to only 6 out of 17 for
24 digestion time. The digestion thus appeared to have proceeded by cleaving the termini
fragments first, after which the reaction proceeded following less selective and extensive
internal hydrolysis, which is in contrast with the previous reports that augmented a high
selectivity that MMP-20 possesses with respect to the cleavage sites on rH174 (28), unlike
the one of KLK-4, the other main protease of the enamel matrix known for its aggressive
cleavage of amelogenin (33, 34). The difference can be explained by the fact that whereas
our proteolysis was initiated in a dynamically changing solution composed of multiple ionic
species and active surfaces, the earlier observed more selective cleavage was observed
following incubation of rH174 and MMP-20 in the standard buffer. A change in the protein
conformation has been shown to take place upon binding of amelogenin onto apatite (35),
which may explain the recent finding of more cleavage sites for amelogenin bound to apatite
surfaces than for amelogenin dispersed in aqueous solution (12). The conditions for
hydrolysis in this study were different from previous studies with regards to the ion
concentration and composition, as MMP-20 cleavage was implemented under crystal growth
conditions for calcium phosphate mineral. Besides conformational changes, certain cleavage
sites on the rh174 could be masked by its simultaneous interaction with mineral ions as well
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as other molecules. As recently shown self-assembly of amelogenin may significantly be
altered in the presence of a mineralization promoting milieu which in return could affect
cleavage of the protein (36). As kinetics of the proteolytic digestion appear to be directly
linked to the time scale that governs precipitation of calcium phosphate, the protein-protease
ratio will present a vital parameter in the growth of enamel-like apatite crystals using a
biomimetic setting such as the one applied in this study.
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The results obtained in this study are in agreement with the previous findings of nucleationpromoting effect that amelogenin from species other than human can exert on metastable
calcium phosphate solutions (37-39). We have additionally shown that hydrolysis of
amelogenin can furthermore accelerate the nucleation of calcium phosphate from metastable
solutions. The current model of matrix-guided crystal growth during enamel maturation is
based on the assumption that amelogenin nanospheres preferentially adsorb onto (hk0) faces
of the growing apatite crystals, thereby allowing the surrounding Ca2+ and PO4 3- ions to
bind onto (001) crystal faces solely and forcing the uniaxial growth of apatite crystals along
the [001] axis. This model, however, does not describe the effect of amelogenin on
nucleation of apatite crystals. Studies supporting this thesis came mostly from experiments
involving either very low supersaturation levels (40), when the majority of the ionic content
may be sequestered by amelogenin, or relatively high concentrations of the protein and high
supersaturation levels (41). The question of whether amelogenin does indeed play a role in
nucleation of enamel crystallites can be best answered by investigating its effect in parallel
with that of more hydrophilic protein species of the enamel matrix, including mainly
ameloblastin and enamelin.
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The experimental setting applied in this work has been demonstrated as valuable in terms of
enabling us to gain insights into the fundamental nature of amelogenesis. Still, it may be
subject to numerous improvements, which will be the topics of the future studies. As noted,
diversifying the polypeptide content would help in designing an even more faithful
biomimetic setting. Here we have introduced MMP-20 only in the initial stage of the process
which may mimic the biological conditions of enamel development, since MMP-20 is
expressed at the early secretory stage of amelogenesis when crystallites are growing
predominatly in length (13). MMP-20 cleavage products are partially reabsorbed by the
ameloblasts but most remain in the matrix, occupying the spaces between crystallites, before
KLK-4 aggressively removes the organic matrix almost completely (16). The timely
removal of the digested protein, which is in biological conditions facilitated by the cellular
action, may also be required for sustaining the uniaxial and site-specific crystal growth (42).
The biomimetic experimental setting based on the continuous and controllable titration of
ions into the self-assembling protein matrix can be functionally upgraded by introducing an
option to deliver each one of these species in a controllable manner and in feedback with the
multi-parametric monitoring of the system. This is in accordance with the in vivo character
of the process where ameloblast play the role of precisely monitoring and delivering the
macromolecular ingredients of the enamel matrix and the ionic precursors for crystal
formation.

Conclusions
Since enamel starts growing from a protein-rich ionic gel, a.k.a. the developing enamel
matrix, the process of protein-guided crystal growth has to be synchronized with the
proteolytic degradation and controlled disappearance of the very protein matrix that guides
the uniaxial growth of the apatite crystals. In order to understand the complex process of
amelogenesis the three elementary aspects of the process – crystal growth, protein selfassembly and selective and time-dependent proteolysis – need to be studied in parallel (25).
The capacity of amelogenin to promote nucleation and crystal growth has been shown here
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to increase in proportion with the extent of its proteolytic degradation by means of MMP-20.
Controlling the rate and the extent of the proteolytic cleavage can thus be used to control the
nucleation and growth rates in a protein-guided crystallization system, such as the one
applied in this study.
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Fig.1.
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SDS-PAGE of proteolytically digested rH174 samples in the continuous titration
experiments at different titration times (as shown). Marker, prestained SDS-PAGE marker
(Invitrogen); A1-A7, rH174/MMP-20 weight ratio 103, B1-B5, rH174/MMP-20 weight ratio
104.
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Fig.2.
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Mass spectra of proteolytically digested rH174 (AMG) samples in the continuous titration
experiments sampled out at various time points (2 min – 24 h). IS stands for “internal
standard”, which is [Glu1]-fibrinopeptide B (m/z = 1570.68 Da). It was spiked in MALDI
matrix for internal mass calibration.
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Fig.3.
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AFM images of FAP/glass seeds from the reaction comprising rH174/MMP-20 in 1:103 (a)
and 1:105 (b) weight ratios, after titration volumes of 1.55 ml (a) and 2.8 ml (b). The average
height of apatite crystals grown after different titration volumes compared between 0.4 mg/
ml rH174 sample without MMP-20 (-o-), with MMP-20 in 105:1 weight ratio (-▫-), and with
MMP-20 in 103:1 weight ratio (-Δ-) with respect to rH174 (c). SEM micrograph of the
cross-section of an FAP substrate at the end of a 7-day titration experiment (d). Dotted line
is a guide for the eye at the titration volume at which the precipitation propensities of the
solutions significantly differ.
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Fig.4.

Time-dependent increase in the particle size of 0.4 mg/ml rH174 assemblies dispersed in
water at 37 °C and pH 7.40 following the introduction of MMP-20 in 100:1 weight ratio (a).
AFM images of amelogenin assemblies at time zero (b) and following the degradation by
means of MMP-20 (c).
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Fig.5.

pH change in the supernatants in the 7-day titration experiments for the control, protein-free
experiment, the one containing only rH174, and the one containing both rH174 and
MMP-20 in 103:1 rH174/MMP-20 weight ratio;

NIH-PA Author Manuscript
Arch Oral Biol. Author manuscript; available in PMC 2012 December 1.

Uskoković et al.

Page 18

NIH-PA Author Manuscript
Fig.6.
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Concentration of free Ca2+ over reaction time in the systems comprising 0.4 mg/ml rH174 (Δ-), 0.4 mg/ml rH174 and MMP-20 (1:103), and no peptide species (-o-) (a), and the
percentage of the overall titrated amount of Ca2+ that is being precipitated and/or proteinbound at different reaction times using [rH174] = 0.4 mg/ml (-□-), [rH174] = 1.6 mg/ml (Δ-), and [rH174] = 0.4 mg/ml, but with the proteolytic reaction coupled to it (-▫-) (b).
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Fig.7.

SEM micrographs of calcium phosphate particles obtained in the presence of rH174 only
(a), and in the presence of both rH174 and MMP-20 in 103:1 (b) and 104:1 (c) rH174/
MMP-20 weight ratios. Obtained at the end of titration experiment at a) 7 ml, b) 7 ml and c)
9.4 ml titration volume.
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Fig.8.

Surface of FAP substrates sampled out after 1.2 (a) and 9.4 ml (b) of the titration volume
observed under SEM/EDX.
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Table 1

List of samples analyzed by means of SDS-PAGE and MALDI-TOF techniques
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Sample

rH174/MMP-20 weight ratio

Titration time

A1

103

2 min

A2

103

17 min

A3

103

30 min

A5

103

2.5 h

A6

103

5h

A7

103

24 h

B1

104

5 min

B2

104

30 min

B3

104

90 min

B4

104

4h

B5

104

24 h
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Twelve (out of ~ 30 in total) and 17 (out of ~ 140 in total) most intense peptides generated from digestion of
rh174 with MMP-20 (104 rH174/MMP-20 weight ratio) for 5 min and 24 h, respectively (see Fig.3d). The
slash mark indicates the cleavage site. The sequence of the X chromosome variant of the recombinant fulllength human amelogenin is given below. C- and N-terminal cleavage sites are marked with a star.
5 min

24 h

m/z (monoisotopic)

Range

m/z (monoisotopic)

Range

1005.54*

1-10*

1395.71*

1-13*

1542.78*

1-14*

1445.73

2-14

1590.78*

162-174*

1456.67

29-40

1629.81*

1-15*

1542.79*

1-14*

1661.80*

161-174*

1569.75

28-40

1792.86*

1-16*

1656.78

27-40

2005.00*

158-174*

1661.81*

161-174*
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2118.08

157-174*

1756.81

29-43

2330.13*

155-174*

1784.85

26-40

2978.52*

149-174*

1790.87*

160-174*

4168.02*

1-36*

1947.91

25-40

13213.2*

1-116*

1956.90

27-43

2043.14

48-65

2118.09*

157-174*

2134.00*

1-19*

2262.07

23-40

3106.58*

148-174*

rH174:
1

PLPPHPGHPGYINFSYEVLTPLKWYQSIRPPYPSYGYEPMGGWLHHQIIPVLSQQHPPTH
TLQPHHHIPVVPAQQPVIPQQPMMPVPGQHSMTPIQHHQPNLPPPAQQPYQPQPVQPQP
HQPMQPQPPVHPMQPLPPQPPLPPMFPMQPLPPMLPDLTLEAWPSTDKTKREEVD174

NIH-PA Author Manuscript
Arch Oral Biol. Author manuscript; available in PMC 2012 December 1.

